Workflow
Emeren(SOL)
icon
Search documents
SOL Global Strengthens Financial Position with Partial Repayment to Senior Lender
Newsfile· 2024-12-11 13:00
Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL" or "the Company") is pleased to announce that it has successfully repaid $3.4 million of its outstanding debt to its senior lender, Braebeacon Holdings Inc., decreasing the loan balance to $10.2 million.This repayment aligns with SOL Global's broader financial objectives and reflects the Company's ongoing commitment to strengthening its financial position and reducing leverag ...
SOL Global Announces Closing of C$3.6 Million Brokered Private Placement of Units
Newsfile· 2024-12-03 14:02
SOL Global Announces Closing of C$3.6 Million Brokered Private Placement of Units100% of Net Proceeds Will be Used for the Purchase of Additional Solana TokensDecember 03, 2024 9:02 AM EST | Source: SOL Global Investments Corp.Toronto, Ontario--(Newsfile Corp. - December 3, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") is pleased to announce that it has closed its previously announced brokered private placement. The Company sold 18 ...
Emeren Group Releases 2023 Environmental, Social and Governance Report
Prnewswire· 2024-12-02 13:00
NORWALK, Conn., Dec. 2, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced the release of its 2023 Environmental, Social, and Governance (ESG) Report. The report highlights the company's achievements in advancing sustainability, fostering inclusivity, and maintaining robust governance, underpinned by a systematic and transparent approach aligned with the Global Reporting Initiative (GR ...
Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1
GlobeNewswire News Room· 2024-12-02 12:30
SOL-1 is the first registrational trial for AXPAXLI™ in wet AMD Topline clinical data from SOL-1 expected in Q4 2025 Active clinical trial sites enrolling patients directly into second registrational trial, SOL-R, while additional sites continue to be activated BEDFORD, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovativ ...
Emeren to Participate in Upcoming Investor Conferences
Prnewswire· 2024-11-21 11:00
NORWALK, Conn., Nov. 21, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced its participation in the following investor conferences: Janney's 2nd Annual Clean Energy Investment Symposium on December 4-5, 2024, in New Orleans, LA. BofA Securities 2024 Clean Energy Symposium on December 5-6, 2024, in New York, NY. The management team will present at a panel at 3:30 p.m. Eastern Time on D ...
SOL Global Announces C$3.6 Million Brokered Private Placement of Units
GlobeNewswire News Room· 2024-11-19 13:51
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SOL Global Investments Corp. (CSE: SOL; OTC Pink: SOLCF) (FSE: 9SB) (“SOL Global” or the “Company”) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (“Canaccord Genuity”) and Clarus Securities Inc. (“Clarus”, and together with Canaccord Genuity, the “Co-Lead Agents”), as co-lead agents and co-bookrunners, and on behalf of a syn ...
Emeren(SOL) - 2024 Q3 - Quarterly Results
2024-11-18 21:05
Financial Performance - In Q3 2024, the company reported revenue of $12.9 million, down 8% year-over-year and 57% quarter-over-quarter, with a gross profit of $5.6 million and a gross margin of 43.8%[20][21][38] - The company achieved a net income of $4.8 million in Q3 2024, a significant increase of $14.2 million year-over-year[24] - The EBITDA for Q3 2024 was $8.5 million, reflecting a substantial improvement of $15.4 million year-over-year and a 138% increase quarter-over-quarter[23] - Net income attributable to common shareholders was $4.8 million, a significant increase from $0.4 million in Q2 2024 and a net loss of $9.4 million in Q3 2023[42] - The company reported a diluted net income per ADS of $0.09, compared to $0.01 in Q2 2024 and a diluted net loss of $0.17 in Q3 2023[42] - Net income for the three months ended September 30, 2024, was $5,674 thousand, compared to a loss of $(9,017) thousand for the same period in 2023, indicating a turnaround in profitability[66] Revenue Guidance and Projections - The company anticipates Q4 revenue between $40 million and $45 million, with a projected gross margin of 20% to 25%[18] - For the full year 2024, the company has adjusted its revenue guidance to a range of $97 million to $102 million, with an expected gross margin of approximately 30%[18] - The company expects IPP revenue for 2024 to be between $24 million and $26 million, with a gross margin of around 50%[19] Project and Contract Developments - The Independent Power Producer (IPP) segment generated $9.4 million, accounting for 73.2% of total revenue, driven by strong performance in European assets[4][13] - The company secured DSA contracts covering 28 projects totaling over 2.1 GW, with expected contracted revenue exceeding $69 million to be monetized within the next 2-3 years[7] - A new DSA was announced for a 300 MW Battery Energy Storage System portfolio in Southern Italy, enhancing the company's position in the Italian market[8] - The project pipeline includes 7,684 MW across advanced and early-stage solar development projects, with Europe holding the majority[29][30] Cash Flow and Liquidity - Cash and cash equivalents at the end of Q3 2024 were $35.8 million, down from $50.8 million in Q2 2024[44] - Cash used in operating activities was $5.6 million, while cash used in investing activities was $4.2 million[43] - Net cash used in operating activities for the three months ended September 30, 2024, was $(5,582) thousand, compared to $(4,643) thousand for the same period in 2023, indicating a worsening cash flow situation[57] - Net cash provided by (used in) investing activities for the three months ended September 30, 2024, was $(4,193) thousand, compared to $10,118 thousand for the same period in 2023, indicating a significant shift in investment cash flow[57] Asset and Liability Management - Total current assets decreased to $211,812 thousand as of September 30, 2024, down from $226,450 thousand as of December 31, 2023, representing a decline of approximately 6.4%[55] - Total liabilities decreased to $110,701 thousand as of September 30, 2024, from $115,042 thousand as of December 31, 2023, reflecting a reduction of approximately 3.8%[55] - Total assets decreased to $470,111 thousand as of September 30, 2024, down from $478,351 thousand as of December 31, 2023, representing a decline of approximately 1.7%[55] - Total shareholders' equity decreased to $359,410 thousand as of September 30, 2024, from $363,309 thousand as of December 31, 2023, a decline of approximately 1.0%[55] - The debt-to-asset ratio at the end of Q3 2024 was 10.18%, slightly down from 10.22% in Q2 2024[46] Market and Industry Outlook - The solar industry is experiencing strong momentum, driven by global commitments to renewable energy, positioning solar as a key part of the future energy mix[47] - The company aims to capitalize on the accelerating adoption of solar technology worldwide, supported by its strong financial foundation and industry partnerships[48] Foreign Exchange and Other Impacts - The company reported a foreign exchange loss of $(4,615) thousand for the three months ended September 30, 2024, compared to a gain of $4,785 thousand for the same period in 2023, highlighting increased volatility in currency impacts[66]
Emeren's Q3 Earnings In Line With Estimates, Revenues Fall Y/Y
ZACKS· 2024-11-18 17:05
Emeren Group Ltd.'s (SOL) share price dropped 4.5% to reach $1.91 on Nov. 15, following its latest quarterly release. Emeren reported an income per American Depositary Share of nine cents for the third quarter of 2024, which came in line with the Zacks Consensus Estimate. The figure reflects an improvement from the year-ago quarter's loss of 17 cents per share. SOL's Revenues Emeren's net revenues of $12.9 million declined 7.2% from $13.9 million reported in the year-ago period. The year-over-year deteriora ...
Emeren(SOL) - 2024 Q3 - Earnings Call Presentation
2024-11-15 00:20
SOL LISTED NYSE NYSE: SOL Q3 2024 Earnings Presentation November 14, 2024 Safe Harbor Statement 2 NYSE: SOL This presentation contains statements that constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Whenever you read a statement that is not simply a statement of historical fact (such as when the C ...
Emeren(SOL) - 2024 Q3 - Earnings Call Transcript
2024-11-15 00:19
Emeren Group Ltd (NYSE:SOL) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Gary Dvorchak - Managing Director, The Blueshirt Group Yumin Liu - CEO Ke Chen - CFO Conference Call Participants Philip Shen - Roth Capital Partners Operator Hello, ladies and gentlemen. Welcome and thank you for standing by, for Emeren Group Limited Third Quarter 2024 Earnings Conference Call. Please note that we are recording today's conference call. [Operator Instructions] I will now turn over ...